Paul Monk
3PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jan 16, 2024
Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide.Wassim Abida, Andrew W Hahn, Neal Shore
|Jan 25, 2021
A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies.Katharine A Collier, Hugo Valencia, Herbert Newton
|Aug 08, 2018
Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC).Paul Monk, Glenn Liu, Walter M Stadler
Pageof 1
Frequent Collaborators
1 joint publications
Katharine A Collier
1 joint publications
Herbert Newton
1 joint publications
Erinn M Hade
1 joint publications
Douglas W Sborov
1 joint publications
Ming Poi
1 joint publications
Mitch A Phelps
1 joint publications
Sophia G Liva
1 joint publications
Christopher C Coss
1 joint publications
Richard Piekarz
1 joint publications
Craig C Hofmeister
